drugset / Trial / NCT02157311

4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients

NCT02157311

Phase 3 Completed 100 enrolled ANRS, Emerging Infectious Diseases
NaSingle-groupOpen-labelTreatment

Summary

Evaluate after 48 weeks, the capacity of a weekly strategy of 4 consecutive days on treatment followed by 3 days off treatment, in HIV-1 treated patients with undetectable viral load for at least 12 months and continuous antiretroviral regimen unchanged for at least 4 months, to maintain a therapeutic success defined by the absence of virological failure (2 consecutive viral loads \> 50 cp/mL) and the absence of interruption of therapeutic strategy (interruption or change of the " 4 days on / 3 days off " strategy for a time longer than 30 consecutive days).

Timeline

Start
2014-07
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Background Abacavir Other / unclassified
Background Atazanavir Other / unclassified
Background Darunavir Small molecule
Background Efavirenz Other / unclassified
Background Etravirine Small molecule
Background Lamivudine Other / unclassified
Background Lopinavir Other / unclassified
Background Rilpivirine Small molecule
Background Tenofovir Small molecule
Background emtricitabine Other / unclassified